M
GLUE//CIK 0001826457
Monte Rosa Therapeutics, Inc.
Market Data
$20.88+$5.57 (+36.38%)
GLUE · Last trade
Prev Close
$15.31
Range (28d)
$14.40 – $25.31
Recent Filings
- 8-K168.1 KBMonte Rosa Therapeutics, Inc.Feb 10, 4:01 PM ET·0001193125-26-044616
- 8-K677.1 KBMonte Rosa Therapeutics, Inc.Jan 9, 4:32 PM ET·0001193125-26-009005
- 8-K169.0 KBMonte Rosa Therapeutics, Inc.Jan 7, 4:17 PM ET·0001193125-26-006341
- 8-K14.0 MBMonte Rosa Therapeutics, Inc.Jan 7, 7:06 AM ET·0001193125-26-005420
- 8-K12.2 MBMonte Rosa Therapeutics, Inc.Dec 16, 7:30 AM ET·0001193125-25-319981
- 10-Q12.2 MBMonte Rosa Therapeutics, Inc.Nov 6, 7:05 AM ET·0001193125-25-268045
- 8-K500.4 KBMonte Rosa Therapeutics, Inc.Nov 6, 7:03 AM ET·0001193125-25-268042
- 8-K215.5 KBMonte Rosa Therapeutics, Inc.Sep 15, 7:01 AM ET·0001193125-25-202760
- 10-Q10.5 MBMonte Rosa Therapeutics, Inc.Aug 7, 7:06 AM ET·0000950170-25-104550
- 8-K472.5 KBMonte Rosa Therapeutics, Inc.Aug 7, 7:03 AM ET·0000950170-25-104545
Insiders
10- BASKETT FOREST10% Owner
- Behbahani AliDirector, 10% Owner
- Blackwell KimberlyDirector
- Bolzon Bradley J PhDDirector, 10% Owner
- Castle John C.Chief Data Scientist
- Champoux JenniferChief Operating Officer
- Chang Carmen10% Owner
- Chen Bihua10% Owner
- Cormorant Asset Management, LPFormer 10% Owner
- Cormorant Private Healthcare Fund III LP10% Owner
Tickers
Addresses
business
321 HARRISON AVENUE SUITE 900
BOSTON, MA, 02118
mailing
321 HARRISON AVENUE SUITE 900
BOSTON, MA, 02118
Former Names
- Monte Rosa Therapeutics, Inc.2026-02-10